Nobiletin mitigates benign prostatic hyperplasia by suppressing prostate cell proliferation through regulation of cell cycle progression, signaling pathways, transcription factor activity, and the androgen-signaling axis
Authors
Wun‐Jae Kim (ORCID: https://orcid.org/0000-0002-8060-8926)
Hoon Kim (ORCID: https://orcid.org/0000-0001-9153-382X)
Nobiletin mitigates benign prostatic hyperplasia by suppressing prostate cell proliferation through regulation of cell cycle progression, signaling pathways, transcription factor activity, and the androgen-signaling axis
Wun‐Jae Kim, Hoon Kim, Seok Joong Yun, Sung‐Kwon Moon et al.
Journal
Frontiers in Pharmacology
Topics
Bioactive Compounds in Plants
article
Nobiletin mitigates benign prostatic hyperplasia by suppressing prostate cell proliferation through regulation of cell cycle progression, signaling pathways, transcription factor activity, and the androgen-signaling axis
Chungbuk National University (KR), Dong-Eui University (KR), Cheongju University (KR), Korea Pharma (South Korea) (KR), Chung-Ang University (KR), Anyang University (KR)
Funders
National Research Foundation, National Research Foundation of Korea, Ministry of Science and ICT, South Korea